Authors:
BOURKE T
CARR A
FENNELLY D
MCDERMOTT E
CROWN J
Citation: T. Bourke et al., IMPROVED DOCTOR PATIENT COMMUNICATION INDEXES IN ONCOLOGY - RESULTS OF A PROSPECTIVE, CONTROLLED EVALUATION AND INTERVENTION BASED ON THE E4 MODEL/, Annals of oncology, 9, 1998, pp. 677-677
Authors:
AGHAJANIAN C
FENNELLY D
SHAPIRO F
WALTZMAN R
ALMADRONES L
OFLAHERTY C
OCONNER K
VENKATRAMAN E
BARAKAT R
CURTIN J
BROWN C
REICH L
WUEST D
NORTON L
HOSKINS W
SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1852-1860
Authors:
DONNELLAN P
ARMSTRONG J
ROWAN S
FENNELLY D
LYNCH V
MCDONNELL T
MCNICHOLAS W
CROWN J
Citation: P. Donnellan et al., NEW CHEMOTHERAPY COMBINATIONS WITH DOCETAXEL IN THE TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(3), 1998, pp. 20-23
Authors:
HUDIS C
RICCIO L
HOLMES F
SEIDMAN A
BASELGA J
CURRIE V
FENNELLY D
GILEWSKI T
MOYNAHAN M
RAPTIS G
SKLARIN N
SURBONE A
UHLENHOPP M
MAICKEL N
YAO TJ
HELLMAN S
USAKEWICZ J
HORTOBAGYI G
NORTON L
Citation: C. Hudis et al., PHASE-II STUDY OF SEMISYNTHETIC PACLITAXEL IN METASTATIC BREAST-CANCER, European journal of cancer, 33(13), 1997, pp. 2198-2202
Authors:
FENNELLY D
AGHAJANIAN C
SHAPIRO F
OFLAHERTY C
MCKENZIE M
OCONNOR C
TONG W
NORTON L
SPRIGGS D
Citation: D. Fennelly et al., PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL ADMINISTERED WEEKLY IN PATIENTS WITH RELAPSED OVARIAN-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 187-192
Authors:
BARAKAT RR
FENNELLY D
PIZZUTO F
VENKATRAMAN ES
BROWN C
CURTIN JP
Citation: Rr. Barakat et al., SALVAGE INTRAPERITONEAL THERAPY OF ADVANCED EPITHELIAL OVARIAN-CANCER- IMPACT OF RETROPERITONEAL NODAL DISEASE, European journal of gynaecological oncology, 18(3), 1997, pp. 161-163
Citation: D. Fennelly et Dp. Kelsen, THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS, Hepato-gastroenterology, 43(8), 1996, pp. 356-362
Authors:
HUDIS C
SEIDMAN A
RAPTIS G
FENNELLY D
GILEWSKI T
BASELGA J
THEODOULOU M
SKLARIN N
MOYNAHAN M
SURBONE A
CURRIE V
LEBWOHL D
UHLENHOPP M
CROWN J
NORTON L
Citation: C. Hudis et al., SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 58-64
Citation: H. Gogas et D. Fennelly, AVASCULAR NECROSIS FOLLOWING EXTENSIVE CHEMOTHERAPY AND DEXAMETHASONETREATMENT IN A PATIENT WITH ADVANCED OVARIAN-CANCER - CASE-REPORT ANDREVIEW OF THE LITERATURE, Gynecologic oncology, 63(3), 1996, pp. 379-381
Authors:
GOGAS H
SHAPIRO F
AGHAJANIAN C
FENNELLY D
ALMADRONES L
HOSKINS WJ
SPRIGGS DR
Citation: H. Gogas et al., THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 61(1), 1996, pp. 22-26
Authors:
VAHDAT L
RAPTIS G
FENNELLY D
HAMILTON N
REICH L
TIERSTEN A
HARRISON M
HUDIS C
MOORE M
YAO TJ
NORTON L
CROWN J
Citation: L. Vahdat et al., RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Clinical cancer research, 1(11), 1995, pp. 1267-1273
Authors:
CROWN J
RAPTIS G
HAMILTON N
FENNELLY D
VAHDAT L
NORTON L
Citation: J. Crown et al., HIGH-DOSE CHEMOTHERAPY OF BREAST-CANCER - CURRENT STATUS AND DEVELOPMENTAL STRATEGIES, European journal of cancer, 31A(5), 1995, pp. 809-811
Authors:
FENNELLY D
SHAPIRO F
SPRIGGS D
AGHAJANIAN C
FRANCIS P
LEWIS JL
JONES W
CURTIN J
BARAKAT R
HOSKINS W
Citation: D. Fennelly et al., PHASE-I STUDY OF TAXOL ADMINISTERED WEEKLY IN PATIENTS WITH PERSISTENT OVARIAN-CANCER, European journal of cancer, 31A, 1995, pp. 923-923
Authors:
FENNELLY D
SCHNEIDER J
SPRIGGS D
BENGALA C
HAKES T
REICH L
BARAKAT R
CURTIN J
MOORE MAS
HOSKINS W
NORTON L
CROWN J
Citation: D. Fennelly et al., DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CYCLOPHOSPHAMIDE, WITH ANALYSIS OF PROGENITOR-CELL MOBILIZATION AND HEMATOLOGIC SUPPORT OF ADVANCED OVARIAN-CANCER PATIENTS RECEIVING RAPIDLY SEQUENCED HIGH-DOSE CARBOPLATIN CYCLOPHOSPHAMIDE COURSES, Journal of clinical oncology, 13(5), 1995, pp. 1160-1166
Authors:
HUDIS CA
SEIDMAN AD
BASELGA J
RAPTIS G
LEBWOHL D
GILEWSKI T
CURRIE V
MOYNAHAN ME
SKLARIN N
FENNELLY D
UHLENHOPP M
RIEDEL E
YAO TJ
NORTON L
Citation: Ca. Hudis et al., SEQUENTIAL ADJUVANT THERAPY WITH DOXORUBICIN PACLITAXEL/CYCLOPHOSPHAMIDE FOR RESECTABLE BREAST-CANCER INVOLVING 4 OR MORE AXILLARY NODES/, Seminars in oncology, 22(6), 1995, pp. 18-23
Authors:
SEIDMAN AD
HUDIS CA
FENNELLY D
RAPTIS G
BASELGA J
NORTON L
Citation: Ad. Seidman et al., MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER, Seminars in oncology, 22(5), 1995, pp. 108-116
Authors:
FENNELLY D
WASSERHEIT C
SCHNEIDER J
HAKES T
REICH L
CURTIN J
YAO TJ
MARKMAN M
NORTON L
CROWN J
Citation: D. Fennelly et al., SIMULTANEOUS DOSE-ESCALATION AND SCHEDULE INTENSIFICATION OF CARBOPLATIN-BASED CHEMOTHERAPY USING PERIPHERAL-BLOOD PROGENITOR CELLS AND FILGRASTIM - A PHASE-I TRIAL, Cancer research, 54(23), 1994, pp. 6137-6142
Authors:
FENNELLY D
SHAPIRO F
SCHNEIDER J
SPRIGGS D
BENGALA C
MCKENZIE M
REICH L
NORTON L
MOORE MAS
CROWN J
Citation: D. Fennelly et al., COMPARATIVE EFFICACY OF BONE-MARROW ENGRAFTMENT FOLLOWING HIGH-DOSE (HD) CARBOPLATIN (CBDCA) PLUS CYCLOPHOSPHAMIDE VERSUS HIGH-DOSE CBDCA TAXOL (TXL), WHEN RESCUED WITH TXL CYCLOPHOSPHAMIDE (CPA) AND GCSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBP), Blood, 84(10), 1994, pp. 10000088-10000088
Authors:
FENNELLY D
BENGALA C
SCHNEIDER J
REICH L
NORTON L
SPRIGGS D
MOORE MAS
CROWN J
Citation: D. Fennelly et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBP) MOBILIZATION USING TAXOL (T) IN COMBINATION WITH CYCLOPHOSPHAMIDE (C) AND GCSF - QUANTITATION AND CORRELATION OF CD34-FORMING-UNIT GRANULOCYTE-MACROPHAGE (CFU-GM), AND MONONUCLEAR CELL (MNC) COUNT( CELL COUNT, COLONY), Blood, 84(10), 1994, pp. 10000105-10000105
Authors:
BENGALA C
FENNELLY D
SHAPIRO F
SCHNEIDER J
REICH L
MOORE MAS
NORTON L
CROWN J
Citation: C. Bengala et al., TAXOL (TXL) IN COMBINATION WITH CYCLOPHOSPHAMIDE (CTX) AND G-CSF CAN IMPROVE THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORS CELLS (PBPCS)IN UNTREATED LOCALLY ADVANCED OVARIAN-CANCER - PRELIMINARY-REPORT, Blood, 82(10), 1993, pp. 10000082-10000082